Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Michelson

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Brain : a Journal of Neurology|November 30, 2020
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brainCyrille Sur, James Kost, David Scott, et al.
Neurology|August 30, 2019
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyMauricio F Farez, Jorge Correale, Melissa J Armstrong, et al.
Journal of Proteome Research|January 25, 2007
Identifying pharmacodynamic protein markers of centrally active drugs in humans: a pilot study in a novel clinical modelSandeep T Patil, Richard E Higgs, John E Brandt, et al.
European Child & Adolescent Psychiatry|September 15, 2004
A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHDJan K Buitelaar, Marina Danckaerts, Christopher Gillberg, et al.
The New England Journal of Medicine|April 11, 2019
Randomized Trial of Verubecestat for Prodromal Alzheimer's DiseaseMichael F Egan, James Kost, Tiffini Voss, et al.
Biological Psychiatry|December 21, 2014
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical TrialsW Joseph Herring, Kathryn M Connor, Neely Ivgy-May, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 13, 2020
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's diseaseAlette M Wessels, Christopher Lines, Robert A Stern, et al.
Neurology|February 14, 2020
Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAshura Williams Buckley, Deborah Hirtz, Maryam Oskoui, et al.
Pediatrics|May 10, 2020
Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled TrialCynthia Sharpe, Gail E Reiner, Suzanne L Davis, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Brain : a Journal of Neurology|November 30, 2020
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brainCyrille Sur, James Kost, David Scott, et al.
Neurology|August 30, 2019
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyMauricio F Farez, Jorge Correale, Melissa J Armstrong, et al.
Journal of Proteome Research|January 25, 2007
Identifying pharmacodynamic protein markers of centrally active drugs in humans: a pilot study in a novel clinical modelSandeep T Patil, Richard E Higgs, John E Brandt, et al.
European Child & Adolescent Psychiatry|September 15, 2004
A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHDJan K Buitelaar, Marina Danckaerts, Christopher Gillberg, et al.
The New England Journal of Medicine|April 11, 2019
Randomized Trial of Verubecestat for Prodromal Alzheimer's DiseaseMichael F Egan, James Kost, Tiffini Voss, et al.
Biological Psychiatry|December 21, 2014
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical TrialsW Joseph Herring, Kathryn M Connor, Neely Ivgy-May, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 13, 2020
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's diseaseAlette M Wessels, Christopher Lines, Robert A Stern, et al.
Neurology|February 14, 2020
Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyAshura Williams Buckley, Deborah Hirtz, Maryam Oskoui, et al.
Pediatrics|May 10, 2020
Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled TrialCynthia Sharpe, Gail E Reiner, Suzanne L Davis, et al.
Pageof 9